Access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries)
Sub-Saharan Africa (IDA & IBRD countries): Access to anti-retroviral drugs, female was 86.3% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries), 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries) is 86.3%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 2.8% on the previous year and up 75.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries) peaked at 86.3% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries), year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.4% | +1860.7% |
| 2003 | 0.6% | +53.0% |
| 2004 | 1.9% | +207.6% |
| 2005 | 3.8% | +98.7% |
| 2006 | 6.7% | +77.1% |
| 2007 | 10.6% | +57.8% |
| 2008 | 14.9% | +40.4% |
| 2009 | 19.4% | +30.6% |
| 2010 | 25.2% | +29.6% |
| 2011 | 31.2% | +23.8% |
| 2012 | 37.4% | +20.1% |
| 2013 | 42.7% | +14.1% |
| 2014 | 49.2% | +15.1% |
| 2015 | 54.6% | +11.1% |
| 2016 | 60.6% | +11.0% |
| 2017 | 66.5% | +9.8% |
| 2018 | 69.3% | +4.2% |
| 2019 | 72.7% | +4.9% |
| 2020 | 75.9% | +4.4% |
| 2021 | 78.7% | +3.7% |
| 2022 | 81.6% | +3.6% |
| 2023 | 84.0% | +3.0% |
| 2024 | 86.3% | +2.8% |
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2002 | +1860.7% | 0.0% | 0.4% |
| 2004 | +207.6% | 0.6% | 1.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.8% | 0.0% | 19.4% | 10 |
| 2010s | 50.9% | 25.2% | 72.7% | 10 |
| 2020s | 81.3% | 75.9% | 86.3% | 5 |
Countries ranked near Sub-Saharan Africa (IDA & IBRD countries)
- 12 Rwanda 97.0% compare
- 12 United Arab Emirates 97.0% compare
More gender data for Sub-Saharan Africa (IDA & IBRD countries)
- Labor force, female 247.09 million (2025)
- Labor force, female, per capita 0.187 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.97 % change on previous year (2025)
- Labor force, female, per square kilometre 9.83 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 1.12 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.5884 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 1.38 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.4268 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 127.7% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries)?
- Access to anti-retroviral drugs, female in Sub-Saharan Africa (IDA & IBRD countries) was 86.3% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Sub-Saharan Africa (IDA & IBRD countries)?
- The highest recorded value was 86.3% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Sub-Saharan Africa (IDA & IBRD countries)?
- The lowest recorded value was 0.0% in 2000.
- How does Sub-Saharan Africa (IDA & IBRD countries) rank for access to anti-retroviral drugs, female?
- Sub-Saharan Africa (IDA & IBRD countries) ranks 10th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Sub-Saharan Africa (IDA & IBRD countries)?
- Over the last ten years it is up 75.6%. The long-run trend across the full record is volatile.
- Where does this Sub-Saharan Africa (IDA & IBRD countries) data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.